CYCS and prostate carcinoma: In a separate cohort, subjects witheither breast  (n = 66) or prostate cancer (n = 38) exhibited significantlyelevated sFas with reduced sFasL and total cytochrome c regardless of age.These markers correlated with disease severity consistent with tumorsubversion of apoptosis.